Figure 6.

Outline of the framework for registry-based MS monitoring on different EEA populations, assuming stable annual MSI (N onsets per year) and MS diagnostic improvement secondary to synergistic effects of improved access to neurological expertise (NE), CSF oligoclonal bands, neurophysiological tests and visual evoked potentials (CSF-EP), and magnetic resonance imaging (MRI).

Alcalde-Cabero et al. BMC Neurology 2013 13:58   doi:10.1186/1471-2377-13-58
Download authors' original image